P

Poseida Therapeutics
D

PSTX

3.31500
USD
-0.225
(-6.36%)
Market Closed
Volume
13,826
EPS
0
Div Yield
0
P/E
-2
Market Cap
246,719,989
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    2.78
    (0.84%)
    335.22 USD
    A
    ASMB
    -0.440
    (-2.95%)
    14.470 USD
    B
    BCRX
    -0.19000
    (-2.61%)
    7.10000 USD
    BMY
    0.620
    (1.30%)
    48.180 USD
    GILD
    0.470
    (0.62%)
    76.510 USD
    I
    INCY
    -0.680
    (-1.05%)
    64.390 USD
    NVS
    0.650
    (0.58%)
    112.100 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
News

Title: Poseida Therapeutics

Sector: Healthcare
Industry: Biotechnology
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline ofautologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.